
Abingworth Bioventures 8 closes on $465m
Abingworth has held a final close for its new life sciences fund, Abingworth Bioventures 8 (ABV 8), on its $465m hard-cap, exceeding its $375m target.
Latest News
DBAG's Ding Gruppe bolts on Bergert Gruppe
Telecommunications service Ding Gruppe now has 1,000 employees and posts €200m in revenues
Nordian Capital sells BouWatch to Haniel
Mergermarket reported that the purchase price values the security systems business at €325m
Penta sells Mecom Group to US-based trade buyer
GP exits the meat-processing company 13 years after acquiring Mecom Humenne in 2008
Octopus-backed SimplyCook acquired by Nestlé
SimplyCook will continue to be led by its founding team from its base in London
Back to Top